Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Virella

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Diabetes Care|March 30, 2004
Role of simvastatin as an immunomodulator in type 2 diabetesMaria F Lopes-Virella, Marina Mironova, Elias Stephan, et al.
Atherosclerosis|September 12, 2012
The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT studyMaria F Lopes-Virella, Kelly J Hunt, Nathaniel L Baker, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 23, 2011
High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetesMaria F Lopes-Virella, Rickey E Carter, Nathaniel L Baker, et al.
Journal of Lipid Research|June 29, 2006
OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophagesAntonio F Saad, Gabriel Virella, Charlyne Chassereau, et al.
Annals of the New York Academy of Sciences|July 23, 2005
The immunogenicity of modified lipoproteinsMaria F Lopes-Virella, Suzanne R Thorpe, M Brooks Derrick, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|March 2, 2005
Safety and immunogenicity of concomitant versus nonconcomitant administration of hepatitis B, tetanus-diphtheria, and measles-mumps-rubella vaccines in healthy eleven- to twelve-year-oldsWilliam M Cassidy, Glenn Jones, Karen Williams, et al.
Clinical and Diagnostic Laboratory Immunology|January 12, 2005
Development of capture assays for different modifications of human low-density lipoproteinGabriel Virella, M Brooks Derrick, Virginia Pate, et al.
Journal of Immunoassay & Immunochemistry|January 18, 2013
Immunoassay of modified forms of human low density lipoprotein in isolated circulating immune complexesGabriel Virella, Joan Colglazier, Charlyne Chassereau, et al.
Clinical Immunology (Orlando, Fla.)|June 6, 2008
Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathyGabriel Virella, Rickey E Carter, Antonio Saad, et al.
The Journal of Biological Chemistry|March 30, 2010
Heat shock protein 70B' (HSP70B') expression and release in response to human oxidized low density lipoprotein immune complexes in macrophagesKent J Smith, Waleed O Twal, Farzan Soodavar, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Diabetes Care|March 30, 2004
Role of simvastatin as an immunomodulator in type 2 diabetesMaria F Lopes-Virella, Marina Mironova, Elias Stephan, et al.
Atherosclerosis|September 12, 2012
The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT studyMaria F Lopes-Virella, Kelly J Hunt, Nathaniel L Baker, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 23, 2011
High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetesMaria F Lopes-Virella, Rickey E Carter, Nathaniel L Baker, et al.
Journal of Lipid Research|June 29, 2006
OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophagesAntonio F Saad, Gabriel Virella, Charlyne Chassereau, et al.
Annals of the New York Academy of Sciences|July 23, 2005
The immunogenicity of modified lipoproteinsMaria F Lopes-Virella, Suzanne R Thorpe, M Brooks Derrick, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|March 2, 2005
Safety and immunogenicity of concomitant versus nonconcomitant administration of hepatitis B, tetanus-diphtheria, and measles-mumps-rubella vaccines in healthy eleven- to twelve-year-oldsWilliam M Cassidy, Glenn Jones, Karen Williams, et al.
Clinical and Diagnostic Laboratory Immunology|January 12, 2005
Development of capture assays for different modifications of human low-density lipoproteinGabriel Virella, M Brooks Derrick, Virginia Pate, et al.
Journal of Immunoassay & Immunochemistry|January 18, 2013
Immunoassay of modified forms of human low density lipoprotein in isolated circulating immune complexesGabriel Virella, Joan Colglazier, Charlyne Chassereau, et al.
Clinical Immunology (Orlando, Fla.)|June 6, 2008
Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathyGabriel Virella, Rickey E Carter, Antonio Saad, et al.
The Journal of Biological Chemistry|March 30, 2010
Heat shock protein 70B' (HSP70B') expression and release in response to human oxidized low density lipoprotein immune complexes in macrophagesKent J Smith, Waleed O Twal, Farzan Soodavar, et al.
Pageof 5